These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26591341)

  • 1. [Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: III. Abnormalities in lipid metabolism in chronic kidney disease].
    Shoji T
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):923-30. PubMed ID: 26591341
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: VIII. Anemia and iron metabolism in chronic kidney disease].
    Yamamoto H
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):960-6. PubMed ID: 26591346
    [No Abstract]   [Full Text] [Related]  

  • 3. [Kidney diseases and metabolic disorders-Basics and applications required for general physicians. Topics: VI. Chronic kidney disease and fragility fracture].
    Kazama JJ
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):948-52. PubMed ID: 26591344
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kidney Diseases and Metabolic Disorders--Basics and Applications Required for General Physicians].
    Narita I
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):901-5. PubMed ID: 26591338
    [No Abstract]   [Full Text] [Related]  

  • 5. [Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: VII. Abnormality in phosphate metabolism].
    Hamano T
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):953-9. PubMed ID: 26591345
    [No Abstract]   [Full Text] [Related]  

  • 6. [Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: V. Acid-base disorders and kidney disease].
    Kaname S
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):938-47. PubMed ID: 26591343
    [No Abstract]   [Full Text] [Related]  

  • 7. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
    Lanktree MB; Thériault S; Walsh M; Paré G
    Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal lipoprotein metabolism in CKD].
    Hirano T
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1276-9. PubMed ID: 24288963
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular mechanism of fatty acids impact on plasma lipid profile (part I)].
    Swierczyński J; Wołyniec W; Chmielewski M; Rutkowski B
    Przegl Lek; 2007; 64(1):37-41. PubMed ID: 18183830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: I. Disorders of water balance and sodium metabolism].
    Ota T; Uchida S
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):906-16. PubMed ID: 26591339
    [No Abstract]   [Full Text] [Related]  

  • 11. [Kidney diseases and metabolic disorders-Basics and applications required for general physicians. Topics: II. Disorder of carbohydrate metabolism].
    Ogata K; Matsumoto T; Ode K; Shinmamura Y; Inoue K; Taniguchi Y; Horino T; Terada Y
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):917-22. PubMed ID: 26591340
    [No Abstract]   [Full Text] [Related]  

  • 12. HDL function and cardiovascular risk: debate continues..
    Stock J
    Atherosclerosis; 2013 Jul; 229(1):38-41. PubMed ID: 23731566
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic ischemic heart disease in lipid metabolism disorders dependent on age].
    Reuter W; Hunecke I
    Z Alternsforsch; 1981; 36(3):197-204. PubMed ID: 7293254
    [No Abstract]   [Full Text] [Related]  

  • 14. [New era of laboratory testing. Topics: II. Particulars; 2. Laboratory testings for diagnosis and management of dyslipidemia].
    Tsukamoto K
    Nihon Naika Gakkai Zasshi; 2013 Dec; 102(12):3117-24. PubMed ID: 24605559
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipid metabolism abnormalities in Chronic Kidney Disease].
    Bianchi S; Baronti A; Cominotto R; Bigazzi R
    G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid disorders and their relevance to outcomes in chronic kidney disease.
    Vaziri ND; Norris K
    Blood Purif; 2011; 31(1-3):189-96. PubMed ID: 21228589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolism of magnesium and lipid disturbances in chronic renal failure].
    Fijałkowska-Morawska J; Chrzanowski W
    Pol Arch Med Wewn; 1997 Oct; 98(10):327-31. PubMed ID: 9557087
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renalase Assessment With Regard to Kidney Function, Lipid Disturbances, and Endothelial Dysfunction Parameters in Stable Renal Transplant Recipients.
    Stojanovic D; Cvetkovic T; Stojanovic M; Stefanovic N; Velickovic-Radovanovic R; Zivkovic N
    Prog Transplant; 2017 Jun; 27(2):125-130. PubMed ID: 28617168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol Metabolism in CKD.
    Reiss AB; Voloshyna I; De Leon J; Miyawaki N; Mattana J
    Am J Kidney Dis; 2015 Dec; 66(6):1071-82. PubMed ID: 26337134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.